November is Men’s Health Awareness Month. Although there are many stigmas attached to men’s health, LaunchWorks is proud to partner with companies aiming to change that mindset and improve the lives of men’s health around the world. 

According to Movember, 1 in 2 men will be diagnosed with cancer in their lifetime. Testicular cancer is the most common cancer in males aged 15-39. Prostate cancer often has no symptoms until it advances, making it the second most common cancer for men. Testing for these cancers includes genomic testing, genetic testing, biopsy of the area or of the Lymph node to determine whether the cancer has spread to additional parts of the body. Even with increasing survival rates, early detection is the key to saving a life and maintaining quality of life. 

Companion diagnostics is one tool providing insights into the early diagnosis, prognosis, therapeutic effectiveness, and monitoring of cancer through molecular testing.  LaunchWorks CDMO partners with companies to develop and optimize cancer diagnostic products for commercial, large-scale manufacturing. LaunchWorks provides an expansive list of services, from creating custom pilot lot kits for high complexity products to fully commercialized kitting and fulfillment.  

LaunchWorks provides testing services that include real-time and accelerated product aging and package testing. Additionally, cold chain packaging for custom cold chain shipping needs can be developed and validated through our affiliate company, Cryopak. 

LaunchWorks is proud to support companies in the fight to improve men’s health and honor those that have lost the battle. For more information about how LaunchWorks supports early detection for men’s health, contact us here. 

LaunchWorks:  

  • FDA Registered 
  • ISO 13485:2016 Certified 
  • cGMP Compliant 
  • Full-Service 
  • Contract Manufacturer